GO:0106137 IkappaB kinase complex binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0106137 (IkappaB kinase complex binding) is a molecular function defined as binding to an IkappaB kinase (IKK) complex, the central kinase assembly that controls NF-kappaB signaling.
• The IKK complex is a multi-subunit machine whose catalytic subunits IKK-alpha (CHUK) and IKK-beta (IKBKB) are activated within the complex and phosphorylate IkappaB proteins to release NF-kappaB.
• Proteins that bind the IKK complex act as scaffolds, activators, or regulators; for example, the E3 ligase RNF32 controls the IKK complex and NF-kappaB signaling in intestinal stem cells, and DCLK1 activates NF-kappaB by binding directly to IKK-beta.
• IKK complex binding is not limited to immune signaling: it regulates mRNA stability, hepatic lipid metabolism in nonalcoholic fatty liver disease, plexin-B-mediated RhoA activation, and intestinal inflammation through AMBRA1-PP4R1/PP4c-dependent IKK dephosphorylation.
• Dysregulated IKK complex binding contributes to inflammatory disease, cancer, and metabolic disorders, making it a target for mechanistic and therapeutic studies.
• CRISPR knockout, point-mutation, knock-in, and overexpression models, combined with interactomics and phospho-signaling assays, are the main tools for dissecting IKK complex binding.
Description
GO:0106137, IkappaB kinase complex binding, is a molecular function term that describes the binding of a protein or other molecule to an IkappaB kinase (IKK) complex. The IKK complex is the master kinase assembly of the canonical NF-kappaB pathway, and its catalytic subunits IKK-alpha (CHUK) and IKK-beta (IKBKB) phosphorylate IkappaB inhibitors, thereby freeing NF-kappaB to enter the nucleus and drive transcription. Because the IKK complex sits at the convergence point of inflammatory, immune, and survival signals, proteins that bind it can profoundly reshape cellular responses. Researchers study IKK complex binding to understand how upstream kinases, scaffolds, and regulatory proteins assemble and tune this signaling hub. For instance, MEKK1 was shown to activate the IkappaB-alpha kinase complex, linking a JNK-pathway kinase to IKK regulation. More recently, the E3 ligase RNF32 was found to control the IKK complex and NF-kappaB signaling in intestinal stem cells, and doublecortin-like kinase 1 (DCLK1) was shown to activate NF-kappaB by binding directly to IKK-beta. These examples illustrate that IKK complex binding is a dynamic, context-dependent function with broad physiological reach. The term is also relevant beyond classical immunity. The IKK complex regulates mRNA stability, is required for plexin-B-mediated RhoA activation, participates in hepatic lipid metabolism and nonalcoholic fatty liver disease, and is modulated by AMBRA1, which antagonizes PP4R1/PP4c-mediated IKK dephosphorylation to promote intestinal inflammation. Thus, GO:0106137 provides a focused annotation for any protein that physically engages the IKK complex, whether as an activator, scaffold, or regulator.
IkappaB kinase complex binding At A Glance
| GO ID | GO:0106137 |
|---|---|
| GO term | IkappaB kinase complex binding |
| Ontology | molecular_function |
| Synonym | (none) |
| Major function | Binding to an IkappaB kinase (IKK) complex, thereby influencing IKK complex assembly, activity, or downstream NF-kappaB signaling |
| Related complex | IkappaB kinase (IKK) complex, containing catalytic subunits IKK-alpha (CHUK) and IKK-beta (IKBKB) |
| Key upstream regulators | MEKK1, RNF32, DCLK1, AMBRA1-PP4R1/PP4c |
| Disease relevance | Inflammatory signaling, intestinal inflammation, cancer, nonalcoholic fatty liver disease |
| Experimental readouts | NF-kappaB reporter assays, IKK phosphorylation, interactomics, mRNA stability assays |
What Is GO:0106137?
In our own words, GO:0106137 (IkappaB kinase complex binding) is the molecular function of selectively and non-covalently interacting with an IkappaB kinase complex. The IKK complex is a multi-protein assembly containing catalytic IKK subunits and regulatory components that together phosphorylate IkappaB proteins and activate NF-kappaB. A protein annotated with this term therefore binds the intact or partially assembled IKK complex, rather than merely one isolated subunit, and may thereby modulate its localization, activity, or substrate access.
Why Is IkappaB kinase complex binding Important in Cell Biology?
GO:0106137 is important because the IKK complex is a central node in NF-kappaB signaling, and any protein that binds it can act as an activator, scaffold, or feedback regulator of inflammatory and survival gene programs. Understanding IKK complex binding therefore clarifies how cells convert diverse stimuli into NF-kappaB output, and it identifies candidate targets for diseases driven by chronic inflammation or aberrant NF-kappaB activity.
• Defines a specific molecular function that distinguishes IKK complex binders from general NF-kappaB pathway components.
• Explains how scaffold and adaptor proteins such as RNF32 control IKK complex activity in intestinal stem cells.
• Links direct IKK-beta binding by DCLK1 to inflammatory NF-kappaB activation.
• Connects IKK complex binding to mRNA stability regulation, expanding its functional scope beyond transcription.
• Implicates IKK complex binding in hepatic lipid metabolism and nonalcoholic fatty liver disease.
• Shows a role in plexin-B-mediated RhoA activation, linking IKK binding to cytoskeletal signaling.
• Highlights AMBRA1 as a regulator that antagonizes PP4R1/PP4c-mediated IKK dephosphorylation in intestinal inflammation.
• Provides a mechanistic basis for targeting IKK complex interactions in inflammatory disease and cancer.
• Supports CRISPR-based functional dissection of IKK complex binders in disease-relevant cell models.
• Offers a clear annotation target for proteomics and interactomics studies of NF-kappaB signaling.
Molecular Mechanism of IkappaB kinase complex binding
Recognition and docking onto the IKK complex
In simple terms: A binding protein must first find and physically dock onto the IKK complex.
IkappaB kinase complex binding begins with selective recognition of the IKK complex by a partner protein. The IKK complex contains catalytic subunits IKK-alpha (CHUK) and IKK-beta (IKBKB) whose activation state and conformation determine which interactors can engage it. For example, DCLK1 binds directly to IKK-beta to activate NF-kappaB, demonstrating that a single catalytic subunit interface can mediate functional IKK complex binding. Similarly, RNF32 controls the IKK complex in intestinal stem cells, indicating that E3 ligases can dock onto the complex and regulate its output.
Catalytic activation of IKK2 within the complex
In simple terms: Once bound, partner proteins can switch the IKK catalytic engine on or off.
Binding events at the IKK complex influence catalytic activation of IKK2 (IKK-beta). Hydrogen-deuterium exchange mass spectrometry (HDX-MS) has been used to analyze catalytic activation of IKK2 in the IkappaB kinase complex, revealing conformational changes that accompany activation. Upstream kinases such as MEKK1 can activate the IkappaB-alpha kinase complex, providing an early example of how binding and phosphorylation events converge on IKK regulation. Thus, IKK complex binding is mechanistically coupled to the catalytic cycle of the complex.
Phosphorylation of IkappaB substrates and NF-kappaB release
In simple terms: The activated IKK complex tags IkappaB for destruction, freeing NF-kappaB.
A key consequence of IKK complex engagement is phosphorylation of IkappaB proteins, which targets them for degradation and releases NF-kappaB. Proteins that bind the IKK complex can therefore indirectly control the duration and amplitude of NF-kappaB transcriptional responses. This substrate-directed output is the functional endpoint that many IKK complex binding studies aim to measure.
Dephosphorylation and negative regulation of IKK
In simple terms: Binding partners can also put the brakes on IKK by recruiting phosphatases.
IKK complex binding is not exclusively activating. AMBRA1 promotes intestinal inflammation by antagonizing PP4R1/PP4c-mediated IKK dephosphorylation in an autophagy-independent manner, showing that the balance between phosphorylation and dephosphorylation of IKK is controlled by proteins that engage the complex. This regulatory layer is critical for preventing excessive or prolonged NF-kappaB activation.
Non-transcriptional outputs of IKK complex binding
In simple terms: IKK binding can change RNA fate and cell shape, not just gene transcription.
The IKK complex is a regulator of mRNA stability, extending its functions beyond NF-kappaB transcription. In addition, the IKK complex is required for plexin-B-mediated activation of RhoA, linking IKK complex binding to cytoskeletal signaling. These non-canonical outputs mean that IKK complex binding should be interpreted in the context of the specific cell type and stimulus.
Metabolic context of IKK complex binding
In simple terms: IKK binding also matters for how the liver handles fat.
IkappaB kinases and TANK-binding kinase 1 have roles in hepatic lipid metabolism and nonalcoholic fatty liver disease, indicating that IKK complex binding proteins can influence metabolic gene programs. This metabolic dimension broadens the disease relevance of GO:0106137 beyond classical inflammation.
Key Genes Involved in GO:0106137 IkappaB kinase complex binding
The following genes and proteins are experimentally linked to IkappaB kinase complex binding or to the IKK complex that this term describes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CHUK (IKK-alpha) | Catalytic subunit of the IKK complex | Core component of the complex bound by GO:0106137 interactors |
| IKBKB (IKK-beta) | Catalytic subunit; direct binding partner of DCLK1 | Central to IKK activation and NF-kappaB signaling |
| RNF32 | E3 ligase that controls the IKK complex | Regulates NF-kappaB signaling in intestinal stem cells |
| DCLK1 | Binds IKK-beta directly to activate NF-kappaB | Links IKK complex binding to inflammatory responses |
| AMBRA1 | Antagonizes PP4R1/PP4c-mediated IKK dephosphorylation | Promotes intestinal inflammation via IKK regulation |
| MEKK1 | Upstream kinase that activates the IkappaB-alpha kinase complex | Early evidence for IKK complex activation by binding/phosphorylation |
| PP4R1 | Regulatory subunit of PP4 phosphatase acting on IKK | Controls IKK dephosphorylation and inflammatory signaling |
| PP4c | Catalytic subunit of PP4 phosphatase | Dephosphorylates IKK in an AMBRA1-regulated manner |
| TBK1 | IkappaB kinase family member | Implicated in hepatic lipid metabolism and NAFLD |
| NFKB1 | NF-kappaB transcription factor released after IkappaB phosphorylation | Downstream effector of IKK complex activity |
| NFKB2 | NF-kappaB family transcription factor | Downstream readout of IKK complex binding events |
| RELA | NF-kappaB subunit | Transcription factor activated by IKK-dependent IkappaB degradation |
| NFKBIA (IkappaB-alpha) | Inhibitor phosphorylated by the IKK complex | Substrate whose phosphorylation reflects IKK complex activity |
| PLXNB1 (plexin-B) | Receptor requiring the IKK complex for RhoA activation | Connects IKK complex binding to cytoskeletal signaling |
| RHOA | Small GTPase activated downstream of plexin-B and IKK | Readout of non-transcriptional IKK complex function |
How Is IkappaB kinase complex binding Regulated?
IKK complex binding and the activity of the bound complex are regulated at multiple levels. Upstream kinases such as MEKK1 can activate the IkappaB-alpha kinase complex, coupling phosphorylation cascades to IKK function. The E3 ligase RNF32 controls the IKK complex and NF-kappaB signaling in intestinal stem cells, showing that ubiquitin-dependent mechanisms regulate IKK complex output. Phosphatase-dependent dephosphorylation provides a negative regulatory layer: AMBRA1 antagonizes PP4R1/PP4c-mediated IKK dephosphorylation to promote intestinal inflammation. In addition, the IKK complex regulates mRNA stability, indicating that post-transcriptional regulation is part of the broader regulatory network. Metabolic contexts, including hepatic lipid metabolism, further modulate IKK family signaling.
IkappaB kinase complex binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| RNF32 | Intestinal inflammation and stem cell signaling | Intestinal organoids with RNF32 knockout |
| DCLK1 | Inflammatory NF-kappaB activation and tumor biology | DCLK1 knockout or point-mutant cancer cell lines |
| AMBRA1 | Intestinal inflammation | AMBRA1 knockout intestinal epithelial cells |
| TBK1 | Nonalcoholic fatty liver disease | Hepatocyte models with TBK1 perturbation |
| PLXNB1 | Cytoskeletal signaling and migration | Plexin-B knockout cells with RhoA readouts |
Intestinal inflammation and inflammatory bowel disease
RNF32 controls the IKK complex and NF-kappaB signaling in intestinal stem cells, linking IKK complex binding to intestinal homeostasis. AMBRA1 promotes intestinal inflammation by antagonizing PP4R1/PP4c-mediated IKK dephosphorylation, providing a direct mechanistic connection between IKK regulation and gut inflammation. These findings suggest that proteins binding the IKK complex are candidate modulators of inflammatory bowel disease.
Cancer and NF-kappaB-driven survival
DCLK1 activates NF-kappaB by binding directly to IKK-beta, and DCLK1 is associated with inflammatory and tumor-promoting responses. Because NF-kappaB supports survival and proliferation, IKK complex binding proteins may contribute to cancer cell resistance to apoptosis. Targeting these interactions is therefore of therapeutic interest.
Nonalcoholic fatty liver disease and metabolic disease
IkappaB kinases and TANK-binding kinase 1 have roles in hepatic lipid metabolism and nonalcoholic fatty liver disease, indicating that IKK complex binding proteins can influence metabolic disease. This expands the disease relevance of GO:0106137 beyond classical immune disorders.
Cytoskeletal signaling and cell migration
The IKK complex is required for plexin-B-mediated activation of RhoA, connecting IKK complex binding to cytoskeletal dynamics and cell migration. Dysregulation of this axis could contribute to developmental or metastatic phenotypes.
From IkappaB kinase complex binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for IKK complex binding and NF-kappaB activation? | CRISPR knockout cell line with NF-kappaB reporter |
| Does a specific residue mediate direct binding to IKK-beta? | Point-mutation knock-in of the binding interface |
| Can a tagged IKK complex be purified for interactomics? | Tagged knock-in of IKBKB or CHUK |
| Does overexpression of a binder amplify inflammatory signaling? | Overexpression cell model with phospho-IkappaB readout |
| Does loss of a regulator alter IKK dephosphorylation? | Knockout of AMBRA1 or PP4R1 with phospho-IKK assays |
| Does IKK complex binding affect mRNA stability? | Knockout or overexpression models combined with mRNA stability assays |
How to Study the IkappaB kinase complex binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Co-immunoprecipitation | Physical interaction with IKK complex subunits | Validating GO:0106137 binding candidates |
| HDX-MS | Conformational changes during IKK2 activation | Structural analysis of IKK complex activation |
| Phospho-immunoblotting | Phosphorylation of IkappaB-alpha and IKK | Functional readout of IKK complex activity |
| NF-kappaB reporter assay | Transcriptional NF-kappaB activity | Testing IKK complex binding consequences |
| RNA-seq with transcription shut-off | mRNA stability changes | Studying IKK-dependent mRNA stability |
| CRISPR knockout screening | Gene requirement for IKK/NF-kappaB signaling | Identifying novel IKK complex binders |
| Proximity labeling proteomics | Proteins near the IKK complex | Mapping the IKK interactome |
Interactomics and binding assays
Co-immunoprecipitation, pull-down, and proximity-labeling approaches can identify proteins that bind the IKK complex. HDX-MS has been applied to analyze catalytic activation of IKK2 in the IkappaB kinase complex, providing structural insight into binding-coupled conformational changes. These methods directly test GO:0106137 annotations.
Phospho-signaling and NF-kappaB reporter assays
Measuring phosphorylation of IkappaB-alpha and IKK subunits, together with NF-kappaB luciferase reporters, quantifies the functional consequence of IKK complex binding. These assays are standard readouts for IKK complex activation.
Transcriptomics and mRNA stability analysis
Because the IKK complex regulates mRNA stability, RNA-seq combined with transcription shut-off experiments can reveal post-transcriptional effects of IKK complex binding. This complements classical NF-kappaB target gene profiling.
Genetic perturbation in disease-relevant cells
Knockout, point-mutation, and knock-in models in intestinal, hepatic, and cancer cell backgrounds allow causal testing of IKK complex binding proteins in disease contexts.
How CRISPR Can Be Used to Study GO:0106137 IkappaB kinase complex binding
Knockout
CRISPR knockout of candidate genes such as RNF32, DCLK1, or AMBRA1 can test whether they are required for IKK complex binding and downstream NF-kappaB activation in disease-relevant cells. Knockout models are the first step in establishing causality for GO:0106137 annotations.
Point Mutation
Point-mutation knock-in can disrupt a specific binding interface, for example the DCLK1-IKK-beta interaction, to determine which residues mediate IKK complex binding without removing the entire protein. This approach separates binding from other functions of the protein.
Knock-in
Tagged knock-in of IKBKB or CHUK enables affinity purification and interactomics of the endogenous IKK complex, allowing unbiased identification of binders under physiological expression levels. Knock-in reporters can also be used to monitor IKK complex dynamics.
Overexpression
Overexpression of a candidate binder can amplify IKK complex binding and reveal gain-of-function effects on NF-kappaB signaling, IkappaB phosphorylation, or mRNA stability. Overexpression models are useful for validating sufficiency in addition to necessity.
How EDITGENE Supports IkappaB kinase complex binding Research
Researchers studying IkappaB kinase complex binding-related genes often need to determine whether a candidate gene is causally involved in IKK complex regulation or is merely correlated with NF-kappaB activation. Establishing causality requires precise genetic models that can remove, mutate, tag, or overexpress the gene of interest in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for IkappaB kinase complex binding research.
Frequently Asked Questions About IkappaB kinase complex binding
What is GO:0106137 IkappaB kinase complex binding?
GO:0106137 is a molecular function term describing binding to an IkappaB kinase (IKK) complex, the kinase assembly that controls NF-kappaB activation.
What genes are involved in IkappaB kinase complex binding?
Key genes include CHUK (IKK-alpha), IKBKB (IKK-beta), RNF32, DCLK1, AMBRA1, MEKK1, PP4R1, PP4c, and TBK1.
How does IKK complex binding activate NF-kappaB?
Binding partners can promote IKK catalytic activation, leading to IkappaB phosphorylation, IkappaB degradation, and NF-kappaB nuclear entry.
Which proteins bind directly to IKK-beta?
DCLK1 has been shown to bind directly to IKK-beta and activate NF-kappaB.
Is IKK complex binding only involved in inflammation?
No. It also regulates mRNA stability, plexin-B-mediated RhoA activation, and hepatic lipid metabolism.
What diseases are linked to IKK complex binding?
Intestinal inflammation, cancer, nonalcoholic fatty liver disease, and cytoskeletal signaling disorders have been linked to IKK complex regulation.
How can I study IKK complex binding in the lab?
Common methods include co-immunoprecipitation, HDX-MS, phospho-immunoblotting, NF-kappaB reporters, and CRISPR perturbation.
What is the role of AMBRA1 in IKK regulation?
AMBRA1 promotes intestinal inflammation by antagonizing PP4R1/PP4c-mediated IKK dephosphorylation in an autophagy-independent manner.
Does the IKK complex regulate mRNA stability?
Yes, the IκB kinase complex has been reported to be a regulator of mRNA stability.
How does RNF32 control IKK signaling?
The E3 ligase RNF32 controls the IκB kinase complex and NF-κB signaling in intestinal stem cells.
Conclusion
GO:0106137 (IkappaB kinase complex binding) captures a mechanistically important molecular function at the heart of NF-kappaB signaling. Proteins that bind the IKK complex can activate, scaffold, or restrain the complex, with consequences for inflammation, cancer, metabolism, mRNA stability, and cytoskeletal signaling. Because IKK complex binding is context-dependent and often non-canonical, rigorous genetic models are essential. CRISPR knockout, point-mutation, knock-in, and overexpression approaches, combined with interactomics and phospho-signaling assays, provide the toolkit needed to define how individual binders shape IKK complex output.
References
- 1. Lauriola A et al.. 2025. The E3 ligase RNF32 controls the IκB kinase complex and NF-κB signaling in intestinal stem cells.. Mol Cell 85(22):4254-4267.e9 PMID: 41167191
- 2. Huh JY et al.. 2021. Roles of IκB kinases and TANK-binding kinase 1 in hepatic lipid metabolism and nonalcoholic fatty liver disease.. Exp Mol Med 53(11):1697-1705 PMID: 34848839
- 3. Luo W et al.. 2023. Doublecortin-like kinase 1 activates NF-κB to induce inflammatory responses by binding directly to IKKβ.. Cell Death Differ 30(5):1184-1197 PMID: 36914767
- 4. Suryajaya W et al.. 2024. HDX-MS Analysis of Catalytic Activation of IKK2 in the IκB Kinase Complex.. Biochemistry 63(18):2323-2334 PMID: 39185716
- 5. Mikuda N et al.. 2018. The IκB kinase complex is a regulator of mRNA stability.. EMBO J 37(24) PMID: 30467221
- 6. Lee FS et al.. 1997. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway.. Cell 88(2):213-22 PMID: 9008162
- 7. Zielonka M et al.. 2014. The IκB kinase complex is required for plexin-B-mediated activation of RhoA.. PLoS One 9(8):e105661 PMID: 25137062
- 8. Xu W et al.. 2024. AMBRA1 promotes intestinal inflammation by antagonizing PP4R1/PP4c mediated IKK dephosphorylation in an autophagy-independent manner.. Cell Death Differ 31(5):618-634 PMID: 38424148
